DR. JAY ALAN FISHMAN, MD

Plain English
This study looked at a new approach to managing immune responses in patients receiving solid organ transplants, specifically using a method called costimulatory blockade. Researchers found that while this method can improve organ function and reduce certain immune responses, it also increases the risk of severe infections and early organ rejection. For example, patients on this treatment were more likely to contract viruses like cytomegalovirus and Epstein-Barr virus. Who this helps: This benefits transplant patients needing safer and more effective immune management during their recovery.

Plain English
This research paper looks at the risks of infections from pigs when using pig organs for human transplants, known as xenotransplantation. The study reviewed over 4,500 pieces of research and highlighted that certain pig viruses, like porcine cytomegalovirus, pose significant risks since they can be passed to humans. Understanding these risks is crucial as it can help make pig organ transplants safer and support addressing the global shortage of human organs. Who this helps: This helps patients in need of organ transplants.

Plain English
Researchers and doctors gathered at the Richard Slayman Workshop to discuss the latest ways to use animal organs for transplants in humans. Key findings included the fact that one patient had a pig kidney working for about nine months, showing promise for future transplants using animal organs. This matters because it could provide a solution to the shortage of human organs for transplant, improving lives and creating new treatment options for patients in need.

Plain English
This study looked at xenotransplantation, which is the process of transplanting organs from pigs to humans, as a solution to the shortage of human organs. Researchers found that while the idea holds promise, there are significant infection risks, both from pig pathogens and from common human infections that can complicate things. Improved methods for monitoring and managing these infections are needed to ensure safer transplants. Who this helps: This benefits patients on waiting lists for organ transplants.

Plain English
This paper discusses the use of pig kidneys as a possible new treatment for patients with severe kidney disease who cannot get a human kidney transplant. Researchers found that genetically modified pig kidneys can function for several months without being rejected when transplanted into brain-dead individuals and a few patients, with reports of survival lasting beyond a year in animal studies. These advances show promise for providing a new option for patients who have limited or no access to human transplants, especially older adults and those with specific health issues. Who this helps: Patients with end-stage kidney disease who cannot receive human kidney transplants.

Plain English
Researchers explored the challenges of using animal organs, particularly pig organs, for transplanting into humans, which could help solve organ shortages. They found that while advances in technology improve safety, there are still risks from infections, including unknown pathogens that could affect patients. They emphasized the importance of safe breeding of source animals and regular health checks to ensure both donors and recipients are free from harmful germs, noting that the risks from specific pig viruses remain unclear. Who this helps: This benefits patients in need of organ transplants and the medical professionals involved in their care.

Plain English
This study looked at the safety of using pig organs in human transplants, a process known as xenotransplantation, to help with the shortage of human organs for people with severe organ failure. Researchers found that managing infectious disease risks is crucial, especially since some infections from pigs could affect humans and there is still uncertainty around how certain viruses, like porcine endogenous retroviruses (PERV), impact human health. By using advanced testing methods, they aim to create better safety protocols for both the organs and the transplant recipients. Who this helps: This helps patients who need organ transplants and the doctors who care for them.

Plain English
This study focuses on using pig kidneys for transplantation in patients with severe kidney disease who cannot receive a human kidney. Researchers have found that genetically modified pig kidneys can survive for more than a year in animal models and have shown promising results in initial human trials without signs of immediate rejection. This is important because it offers a potential solution for patients who have exhausted options for kidney donations and are at high risk. Who this helps: Patients with end-stage renal disease who cannot receive a human kidney transplant.

Plain English
This study focused on how to manage infections when transplanting a pig kidney into a human for the first time. Researchers found that careful screening of the pig donor and thorough monitoring of the human recipient for infections were crucial to prevent potential health issues related to both pig and human germs. This matters because it helps ensure the safety of such groundbreaking transplants and sets guidelines for future procedures. Who this helps: This helps patients receiving animal organ transplants and the doctors performing these procedures.

Plain English
This research paper examines pneumonia in patients who receive thoracic organ transplants, a group at high risk for severe illness due to weakened immune systems. It highlights how advanced testing methods, like new DNA techniques, have improved the ability to diagnose pneumonia quickly and accurately. The study emphasizes the importance of preventing pneumonia through careful management of medications and suggests that ongoing research is needed to refine prevention strategies, particularly concerning treatment duration and dosing. Who this helps: This benefits patients who have received thoracic organ transplants, as well as the doctors who care for them.

Plain English
This research paper focuses on Pneumocystis jiroveci pneumonia (PJP), a serious lung infection that mainly affects patients with weakened immune systems, like those with HIV. The review highlights that diagnosing PJP is tricky, especially in non-HIV patients, and suggests that better tests are needed to ensure timely and effective treatment. While the main medication hasn't changed much, researchers are exploring new treatment combinations, and understanding how to prevent PJP is becoming more critical due to possible infection spreads in healthcare settings. Who this helps: Patients with weakened immune systems, particularly those not living with HIV, as well as doctors treating these patients.

Plain English
This study explored the use of a genetically modified pig kidney as a transplant for a 62-year-old man suffering from severe kidney disease who was reliant on dialysis. The transplant was successful at first, as his kidney function improved quickly, his creatinine levels dropped, and he no longer needed dialysis. Unfortunately, he died 52 days later from heart problems unrelated to the kidney transplant, but the kidney itself continued to function well during that time. Who this helps: This research benefits patients waiting for kidney transplants and those with end-stage kidney disease.

Plain English
This research focused on a patient with heart disease who received a heart transplant from a genetically modified pig. After the transplant, doctors found a pig virus in the patient’s blood, which contributed to the heart failing. This study is important because it highlights the risks of infection and the need for careful management when using animal organs for human transplants. Who this helps: This helps doctors and patients considering xenotransplantation as a treatment option.

Plain English
This study looked at xenotransplantation, where organs or cells from animals, like pigs, are used for human transplants to address the shortage of human organs. The researchers found that the biggest risk with this approach is the potential for transferring animal viruses to patients, but with proper screening and monitoring, these risks can be managed. This is important because it means that clinical trials for xenotransplantation can move forward, which could help many people in need of organ transplants. Who this helps: Patients needing organ transplants.

Plain English
This research paper discusses the potential for using kidneys from specially modified pigs for transplants in humans. The authors found that pig kidneys may work better in humans than in other primates, and they argue that starting small clinical trials with patients who urgently need a transplant could speed up the process of making this treatment available. For instance, more than 9,000 patients on the kidney transplant waiting list in the USA die or are removed from the list each year, which highlights the urgency of finding new solutions. Who this helps: This helps patients with kidney failure who are at high risk of dying while waiting for a transplant.

Plain English
This study looked at how the human cytomegalovirus (CMV) affects immune cells called monocytes. It found that CMV weakens monocytes' abilities to fight off infections by reducing their functions like eating pathogens and presenting them, while causing them to produce more inflammation-related substances. This is important because it shows how CMV can lead to increased infection risks and complications, especially for people with weakened immune systems, like those who have received organ transplants. Who this helps: This helps patients with weakened immune systems, particularly organ transplant recipients.

Plain English
This study looked at whether adding glucocorticoids to the treatment of Pneumocystis jirovecii pneumonia (PJP) in solid organ transplant recipients (SOTRs) helps reduce the rates of ICU admissions and deaths. Among 172 patients studied, 43.4% were admitted to the ICU and 20.8% died; however, glucocorticoid therapy did not lower these rates, indicating it may not be as beneficial as previously thought. The results suggest that doctors should reconsider the routine use of glucocorticoids for treating PJP in transplant patients and call for more research on how to best manage this condition. Who this helps: This helps patients who are solid organ transplant recipients diagnosed with PJP.

Plain English
This study explored the use of animal organs for human heart and lung transplants to address the shortage of human donor organs. Researchers have made progress in editing genes to reduce rejection and inflammation when using these animal organs, but there are still many questions about genetic changes needed, safe research setups, and the risk of diseases transferring from animals to humans. This research is important because it could lead to new transplant options for patients in need and raise important ethical questions about the processes involved. Who this helps: This helps patients waiting for heart and lung transplants.

Plain English
This study focused on detecting porcine cytomegalovirus (PCMV) in pigs, particularly distinguishing between actively infected and latently infected animals. Researchers developed new testing methods using blood samples and specific proteins from the virus, achieving accurate differentiation in 95% of tested cases. This advancement is crucial as it could enhance the safety of using pig organs for transplants in humans, potentially preventing early transplant failures. Who this helps: This benefits doctors and researchers involved in organ transplantation and patients needing organ transplants.

Plain English
In June 2022, a meeting organized by the FDA focused on developing rules for new treatments that involve transplanting organs from animals, specifically pigs, into humans. The discussion covered important topics such as how well pig kidneys work, the need for clinical trials, and ethical concerns. Understanding these issues is crucial because they guide how safely and effectively these xenotransplant treatments can be tested and used for patients in the future. Who this helps: Patients in need of organ transplants.

Plain English
This study looked at the risks of using pig organs for transplants in humans because of possible infections from germs and parasites that pigs might carry. Researchers identified 255 different microorganisms and parasites, and they sorted them into three groups based on their potential danger: 130 were too risky to use, 40 were still a concern but could be managed, and 85 needed to be monitored but were not currently found in the U.S. Most of the risky germs can be controlled with strict safety measures. Who this helps: This research benefits patients needing organ transplants and the doctors involved in xenotransplantation.

Plain English
Robert H. Rubin was a pioneering doctor who studied how infections affect patients who have received organ or stem cell transplants. His work laid the groundwork for better ways to prevent and treat infections in these patients, significantly improving their chances of survival. This research is important because it enhances the longevity and quality of life for transplant recipients. Who this helps: Patients who have undergone organ or stem cell transplants.

Plain English
This study looked at the risks of infections from pigs to people receiving pig organ transplants, known as xenotransplantation. Researchers found that while there are concerns about certain pig viruses, like porcine cytomegalovirus, with careful monitoring and infection control, the risks can be managed. This is important because it means that with the right safety measures, doctors can continue to explore the use of pig organs to help patients in need of transplants.

Plain English
This study examined how well antibody measures against the coronavirus in transplant patients reflect their overall immune response, especially against new virus variants. The authors argue that relying solely on these antibody levels might mislead doctors since they don't capture all aspects of the immune response that are important for patient care. This matters because a better understanding of immune responses can lead to improved treatment strategies for transplant patients. Who this helps: This helps transplant patients and their doctors.

Plain English
This study looked at how to safely use organs from donors who might carry infections, especially in light of the opioid crisis. Researchers reviewed recipient cases at the MGH Transplant Center and found that while many organ recipients tested positive for certain viruses, no actual transmissions of hepatitis C, hepatitis B, or HIV occurred. This matters because it shows that with careful testing and vaccination, risky organs can still be safely transplanted, potentially saving more lives. Who this helps: This helps patients needing organ transplants, as it expands their options for receiving organs.

Plain English
This study focuses on pneumonia caused by a fungus that particularly affects people with weakened immune systems, like those who have recently had organ transplants. Researchers found that this type of pneumonia often develops within six months after transplantation and can be triggered by prolonged use of certain medications or previous infections. Understanding how this pneumonia develops and how to accurately diagnose it is crucial because it can lead to severe health issues in vulnerable patients. Who this helps: This knowledge benefits patients with weakened immune systems, doctors treating them, and healthcare providers working to prevent infections.

Plain English
This study looked at the risks of infections when using pig organs for transplants in humans with weakened immune systems. It found that while some risks from bacteria and parasites are similar to those already seen in humans, there are serious concerns about unknown viruses from pigs that could cause infections in these patients. Understanding and managing these risks is crucial as trials for using pig organs are being planned, ensuring safety for both patients and healthcare providers.

Plain English
This research paper looked at how to manage the use of immunosuppressive drugs in organ transplant patients to balance the risk of organ rejection and the risk of infections. It found that there aren't good tests to measure how well a patient’s immune system is working while they are on these medications, which can lead to infections. The findings highlighted the need for better strategies to adjust these drugs during infections, which is important because managing infections effectively can improve transplant success rates. Who this helps: This helps organ transplant patients.

Plain English
This study looked at how wearable devices, like smartwatches, can help detect COVID-19 and other infections early in solid organ transplant recipients and their families. Researchers found that these devices could identify COVID-19 before symptoms show in over 80% of adults. This early detection is important because it allows for timely interventions, like self-isolation and medical care, to manage infections better and protect vulnerable patients.

Plain English
This study looks at Pneumocystis jiroveci, a fungus that causes pneumonia, especially in people with weakened immune systems, such as patients who have had organ transplants or certain infections. It highlights that pneumonia from this fungus typically occurs within 6 months after organ transplants, with symptoms like fever and difficulty breathing. The main treatment is the antibiotic trimethoprim-sulfamethoxazole (TMP-SMX), while early use of corticosteroids can also help. Who this helps: This research benefits patients with weakened immune systems and their doctors.

Plain English
This study looked at how COVID-19 affects people who have had organ transplants and have weakened immune systems. Researchers found that understanding how the virus behaves in these patients is crucial for improving their treatment and stopping the virus from spreading. This is important because it helps health care providers take better care of vulnerable patients during the pandemic. Who this helps: This helps transplant patients and their doctors.

Plain English
This study looked at how cytomegalovirus (CMV) affects immune cells called monocytes in transplant patients. The researchers found that CMV-infected monocytes struggle to fight off fungal infections and have increased inflammatory responses linked to complications like organ rejection. Specifically, CMV reduces the ability of these cells to recognize and engulf fungi while boosting factors that can lead to organ transplant issues. Who this helps: This research benefits transplant patients by providing insights that could improve their treatment and outcomes.

Plain English
This study looked at preventing infections in patients who receive organ transplants from genetically modified pigs. Researchers found that using pigs raised in clean environments without certain harmful germs—called "designated pathogen-free" pigs—could reduce the risk of new infections in patients. This is important because it can lead to safer transplant procedures and better health outcomes for patients who need organ donations. Who this helps: This benefits patients receiving pig organ transplants and the doctors who perform the surgeries.

Plain English
This study looked at how COVID-19 affects patients who have received organ transplants and whether they experience different disease progression compared to others. Out of 52 transplant patients with COVID-19, 77% were hospitalized, 35% went to the ICU, and 16% died from the virus. The researchers found that inflammatory markers in these patients showed a unique pattern, peaking later in their illness, especially for those in the ICU. Who this helps: This information is valuable for doctors managing care for transplant patients with COVID-19.

Plain English
This study looked at how COVID-19 affected Latinx patients compared to other racial and ethnic groups in 12 hospitals in Massachusetts from February to April 2020. The researchers found that 25% of the COVID-19 patients were Latinx, and among those hospitalized, 39% needed intensive care, which is higher than the rates for White (30%), African American (33%), and Asian American (24%) patients. This matters because it highlights serious health disparities; Latinx and African American patients were hospitalized at about double the rate of White patients, even when considering other health issues. Who this helps: This research helps patients and healthcare providers understand the increased risks for Latinx and African American populations during the pandemic.

Plain English
This study looked at how the spread of other respiratory viruses changed during the COVID-19 pandemic. Researchers found that in areas where COVID-19 was very common, cases of other respiratory viruses decreased significantly because measures to prevent the spread of COVID-19 also reduced the transmission of these other viruses. This matters because understanding these changes can help improve future approaches to managing respiratory illnesses. Who this helps: Patients and public health officials.

Plain English
This study focused on transplanting pig hearts into humans, known as xenotransplantation. Researchers found that patients who received these genetically modified pig hearts survived for more than 90 days with the help of a new drug treatment. This progress could lead to more effective heart transplants for people who need them. Who this helps: This benefits patients with severe heart disease who are waiting for transplants.

Plain English
This study explores the infection risks associated with using pig organs for transplantation in humans, known as xenotransplantation. It found that infections after such procedures are likely, and there are uncertainties about which specific pathogens could be involved. The research emphasizes that thorough screening of the pig donors and careful monitoring of human recipients will be essential as clinical trials progress. Who this helps: This helps patients awaiting organ transplants, as well as doctors involved in transplant procedures.

Plain English
This study focused on creating a model to study B-cell lymphomas, a type of blood cancer, using miniature pigs. Researchers successfully transplanted tumor cells from these pigs into both other pigs and mice, confirming that the tumors grew in all cases. This work is important because it creates a new way to test cancer treatments in a setting that closely resembles how they would work in humans. Who this helps: Cancer researchers and patients who may benefit from new treatments.